Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Phase 1 study of intratumoral administration of JNJ-87704916 an oncolytic virus as monotherapy and in combination for advanced solid tumors

    This is a phase 1 study, testing the study medicine JNJ-87704916 (an oncolytic herpes simplex virus type 1, HSV-1) alone or in combination with another ...

    View Details

  • Measuring the impact of integrated GI behavioral health care in the form of individual and support group psychotherapy in a single IBD center

    This study will track health related quality of life (HRQOL), psychiatric symptoms and inflammatory bowel disease (IBD) activity over time in patients with IBD undergoing ...

    View Details

  • BiorEsorbable SiroLimus-ElutIng Scaffold TreatmEnt for Below The Knee Disease ELITE-BTK Trial

    The purpose of this research is to is to evaluate the investigational MAGNITUDE® Bioresorbable Drug-Eluting Scaffold (MAGNITUDE Scaffold) to treat narrowed or blocked leg arteries ...

    View Details

  • Biological and Imaging Markers to Understand and Predict Progression of Joint Damage after Injury

    This study aims to study joint health after an anterior cruciate ligament (ACL) (band of tissue in the knee) injury both in the short and ...

    View Details

  • A Phase 2 randomized open-label active-controlled study of JNJ-90301900 in combination with chemoradiation followed by durvalumab in locally advanced and unresectable Stage III non-small cell lung cancer

    This is a Phase 2 study testing whether adding a new medicine, JNJ-90301900 (radioenhancer) to the standard treatment of chemotherapy and radiation, followed by a ...

    View Details

  • A Sibling Oocyte Study- Comparison of ZyMotTM Microfluidics Device to Density Gradient for Sperm Selection During ICSI

    The primary purpose of this research is to evaluate whether ZyMot, a microfluidic sperm processing device, will lead to a higher percentage of better-quality embryos ...

    View Details

  • A Phase 3 Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sj gren s Syndrome With Moderate-to-Severe Symptom State

    The Oasiz-303 Study is evaluating the safety and effectiveness of an investigational medicine in people living with Sjögren’s. This investigational medicine works differently from ...

    View Details

  • A Randomized Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wildtype Recurrent Unresectable or Metastatic Colorectal Cancer Who Have Received Prior Chemotherapy

    This is a randomized, open-label, active-controlled, parallel-group, multicenter, interventional, Phase 3 study of amivantamab and FOLFIRI compared with cetuximab or bevacizumab (investigator’s choice) and ...

    View Details